Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | SAGE Sage Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 6.14 | 19,154 | 117.61 k | 19,154 |
12 Sep 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 2.5342 | 40,000 | 101.37 k | 233,464 |
10 Jun 24 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 10.9 | 12,500 | 136.25 k | 12,500 |
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 91,180 | 0.00 | 225,964 |
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 120,000 | 241.20 k | 120,000 |
5 Mar 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 18.7279 | 1,792 | 33.56 k | 134,784 |